| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9319361 | European Urology | 2005 | 7 Pages |
Abstract
our study suggests that the use of ellagic acid as support therapy reduces chemotherapy induced toxicity, in particular neutropenia, in HRCP patients; however, further studies are required to confirm our results.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mario Falsaperla, Giuseppe Morgia, Alfredo Tartarone, Raffaele Ardito, Giampiero Romano,